ALXN Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

$171.85  +1.42 (0.83%)
As of 05/10/2021 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2001
Outstanding shares:  221,019,230
Average volume:  2,447,200
Market cap:   $37,542,326,408
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    015351109
ISIN:        US0153511094
Sedol:      2036070
Valuation   (See tab for details)
PE ratio:   55.25
PB ratio:   3.03
PS ratio:   6.00
Return on equity:   5.49%
Net income %:   10.89%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy